Dr Melissa Kari Gilmore, MD | |
3259 Catlin Ave, Quantico, VA 22134-5109 | |
(703) 784-1751 | |
(770) 784-1895 |
Full Name | Dr Melissa Kari Gilmore |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 3259 Catlin Ave, Quantico, Virginia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144261496 | NPI | - | NPPES |
00751022A | Medicaid | GA | |
02801370 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 43751 (Georgia) | Secondary |
208000000X | Pediatrics | 0101251441 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Melissa Kari Gilmore, MD 3259 Catlin Ave, Quantico, VA 22134-5109 Ph: (703) 784-1751 | Dr Melissa Kari Gilmore, MD 3259 Catlin Ave, Quantico, VA 22134-5109 Ph: (703) 784-1751 |
News Archive
ARUP Laboratories, a leading national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, today announced it is offering the Septin 9 methylated DNA test, a new blood-based colorectal cancer screening method. While ARUP is not the first laboratory to offer this test, this new version, developed and validated independently by ARUP, is clinically proven to detect a higher proportion of colorectal cancers than Septin 9 tests developed by other companies.
The American Gastroenterological Association Research Foundation has received a generous gift from prominent San Francisco philanthropist Athena Blackburn, which will create new research opportunities for young investigators who are interested in neuroenteric disease.
Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. announced today that the U.S. Food and Drug Administration has accepted for review the complete response submission made by Endo to the new drug application for its long-acting testosterone undecanoate injection, AVEED, intended for men diagnosed with hypogonadism.
COPD is defined as a preventable and treatable disease associated with significant extrapulmonary consequences that may contribute to severity. The pulmonary component of COPD is characterised by airflow limitation that is not fully reversible. The airflow limitation is usually progressive with an abnormal inflammatory response of the lungs to noxious particles (GOLD Strategy Document). Airflow obstruction in COPD is not highly variable and largely irreversible.
› Verified 8 days ago
Dr. Timothy William Dwyer, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: Naval Health Clinic Quantico, 3259 Catlin Ave, Quantico, VA 22134 Phone: 703-784-5541 | |
Ms. Lucille Lynn Gerona, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3259 Catlin Ave, Quantico, VA 22134 Phone: 703-784-1627 Fax: 703-784-1987 |